Quotes 5-day view End-of-day quote Hong Kong Stock Exchange
01/15/2021
01/18/2021
01/19/2021
01/20/2021
01/21/2021
Date
103
104.6
110.8
116.6
114.4
Last
15394070
8223990
23046950
19108140
17214550
Volume
-1.62%
+1.55%
+5.93%
+5.23%
-1.89%
Change
Sales 2020
5 403 M
835 M
835 M
Net income 2020
1 482 M
229 M
229 M
Net cash position 2020
4 624 M
715 M
715 M
P/E ratio 2020
264x
Yield 2020
-
Sales 2021
8 064 M
1 246 M
1 246 M
Net income 2021
2 108 M
326 M
326 M
Net cash position 2021
3 842 M
594 M
594 M
P/E ratio 2021
189x
Yield 2021
-
Capitalization
390 B
60 374 M
60 302 M
EV / Sales 2020
71,4x
EV / Sales 2021
47,9x
Nbr of Employees
5 694
Free-Float
-
WUXI BIOLOGICS (CAYMAN) INC. is an investment holding company. The Company along with its subsidiaries is mainly engaged in the discovery, research and development, manufacturing and sales of biologics products. The Company’s primary products include the clinical active pharmaceutical ingredients, sterile liquid preparations, freeze-dried preparations, as well as small molecules antibiotics for injection drugs....
Notations Surperformance© of WuXi Biologics (Cayman) Inc.
Trading Rating :
Investor Rating :
All news about WUXI BIOLOGICS (CAYMAN) INC.
News in other languages on WUXI BIOLOGICS (CAYMAN) INC.
Analyst Recommendations on WUXI BIOLOGICS (CAYMAN) INC.
Alibaba, Xiaomi to join Hong Kong's Hang Seng Index
Chart WUXI BIOLOGICS (CAYMAN) INC.
Duration :
Auto.
2 months
3 months
6 months
9 months
1 year
2 years
5 years
10 years
Max.
Period :
Day
Week
Technical analysis trends WUXI BIOLOGICS (CAYMAN) INC.
Short Term Mid-Term Long Term Trends Bullish Bullish Bullish
Income Statement Evolution
Please enable JavaScript in your browser's settings to use dynamic charts.
Mean consensus
BUY
Number of Analysts
25
Average target price
82,03 CNY
Last Close Price
95,37 CNY
Spread / Highest target
22,4%
Spread / Average Target
-14,0%
Spread / Lowest Target
-52,1%
Please enable JavaScript in your browser's settings to use dynamic charts.